La chaîne d'options affiche les données clés des options sur actions de CFSB Bancorp à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour CFSB Bancorp..

CFSB Bancorp (NASDAQ:CFSB) Stock, Chaîne d'Options

CFSB Bancorp

CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.

CFSB Bancorp Inc

News

AUPH

Aurinia's AURORA 1 Analysis Links Ultra-Low Proteinuria with Favorable Lipidomic Profiles in Lupus Nephritis

Atour Lifestyle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>) raises FY2025 sales outlook from $1.24 billion to $1.24 billion-$1.29 billion vs $9.10 billion estimate.

Guidance

ATAT

Atour Lifestyle Holdings Raises FY2025 Sales Guidance from $1.24B to $1.24B-$1.29B vs $9.10B Est

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.beigene.com%2F&amp;esheet=54258273&amp;newsitemid=20250522213317&amp;lan=en-US&amp;anchor=BeiGene&amp;index=1&amp;md5=b2e553cdb745c6a1895871c2f5165006">BeiGene</a>, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>, HKEX: 06160, SSE: 688235))), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share 23 abstracts featuring new data across its hematology and solid tumor portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, May 30 – June 3, 2025. With two abstracts selected for rapid oral presentation, these data reflect the Company's vision to address cancer across multiple fronts and provide innovative medicines to as many patients as possible worldwide.
"ASCO is a powerful platform for highlighting progress in cancer care, and we're proud to contribute 23 accepted abstracts that reflect our mission to improve outcomes for more patients around the world," said Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeiGene. "From long-term follow-up results for BRUKINSA in CLL to first-time clinical data for two promising breast cancer assets, our presentations this year speak to the depth and momentum of our oncology portfolio — and our commitment to delivering transformative medicines across a range of cancers."
Presentations feature the impressive clinical profile of BRUKINSA(zanubrutinib) across broad patient populations; notable highlights include:
<ul>
<li>Long-term data from SEQUOIA Arm C, which evaluated BRUKINSA in patients with treatment naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with del(17p) mutations.</li>
<li>First results from the full population from Arm D of the SEQUOIA study, which evaluated BRUKINSA plus venetoclax in patients with TN CLL/SLL with and without del (17p) and/or TP53 mutation.</li>
<li>Robust analyses across clinical trials and real-world evidence that deepen understanding of treatment patterns, safety, and outcomes in CLL and mantle cell lymphoma (MCL).</li>
<li>Highlights include new comparative efficacy data for BRUKINSA versus fixed-duration regimens based on a network meta-analysis, as well as real-world studies evaluating BTK inhibitor use, treatment disparities, and clinical outcomes across diverse patient populations.</li>
</ul>
Early phase data includes never-before-presented clinical data from BeiGene's emerging breast cancer pipeline; notable highlights include:
<ul>
<li>Preliminary results of the dose escalation study for BG-C9074, a topoisomerase inhibitor antibody-drug conjugate (ADC) targeting the B7-H4 protein, in patients with advanced solid tumors, including breast cancer.</li>
<li>Early clinical activity for BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure, supporting its development as a next-line option for tumors with CDK2 dependency.</li>
</ul>
Results from the final analysis of the RATIONALE-213 study demonstrate that, using a PET-guided approach, TEVIMBRAplus chemotherapy or chemoradiotherapy showed promising efficacy and a tolerable safety profile in the neoadjuvant setting for resectable esophageal squamous cell carcinoma (ESCC), in both patients who responded and did not respond to preoperative chemotherapy. This adds further evidence to the PD-1 inhibitor's established ability to deliver clinically meaningful efficacy benefits as well as its consistent safety profile.

BeiGene to Present 23 Cancer Drug Studies at ASCO, Including Data on BRUKINSA and Breast Cancer Treatments

Gene Munster, Managing Partner at Deepwater Asset Management, warned Wednesday that OpenAI represents the first serious competitive threat to Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) in two decades following the artificial intelligence company&#8217;s $6.5 billion acquisition of former Apple design chief Jony Ive&#8216;s hardware startup.
What Happened: &#8220;The real risk for AAPL is whether the threat of these devices from OpenAI compresses Apple&#8217;s multiple,&#8221; Munster wrote on X, highlighting concerns about the iPhone maker&#8217;s premium valuation amid intensifying AI competition.
OpenAI announced plans to acquire io Products, Ive&#8217;s AI device startup, in an all-stock transaction that values the company at $6.5 billion despite having no revenue. The deal adds Ive and approximately 55 hardware engineers to OpenAI&#8217;s team as the ChatGPT maker pivots into consumer <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45550033/openai-teams-up-with-iphone-designer-jony-ive-as-chatgpt-maker-makes-push-into-hardware-apple-shares-slide">devices expected to launch in 2026</a>.
Munster characterized the move as part of a generational technology shift comparable to the internet and smartphone revolutions. &#8220;Before AI, there was no real threat to Apple&#8217;s or Google&#8216;s business,&#8221; he noted, emphasizing that OpenAI is &#8220;catalyzing this shift into something tangible.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The real risk for AAPL is whether the threat of these devices from OpenAI compresses Apple's multiple. <a href="https://t.co/z6CqfMGcpA">https://t.co/z6CqfMGcpA</a>
&mdash; Gene Munster (@munster_gene) <a href="https://twitter.com/munster_gene/status/1925245923694620994?ref_src=twsrc%5Etfw">May 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45556607/bitcoin-clocks-110000-ethereum-dogecoin-extend-gains-experienced-trader-peter-brandt-speculates-btc-to-enter-this-range-by-august-end">Bitcoin Clocks $110,000, Ethereum, Dogecoin Extend Gains: Well-Known Trader Peter Brandt Says BTC Could Gain Another 37% As Soon As August</a>
Why It Matters: The acquisition triggered over 2% decline in Apple shares on Wednesday as investors weighed the competitive implications. Ive, who designed iconic Apple products including the iPhone, left the company in 2019 after nearly three decades.
However, Munster tempered concerns about Apple&#8217;s competitive position, citing the company&#8217;s ecosystem lock-in with an estimated 1.7 billion users across 2.35 billion active devices. &#8220;It&#8217;s going to take more than a great phone from OpenAI to get Apple users to walk away from a decade of investment in hardware and services,&#8221; he said.
The analyst suggested Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) faces greater risk, noting that Google&#8217;s ecosystem integration is &#8220;not nearly as strong&#8221; as Apple&#8217;s hardware-software integration.
OpenAI previously <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45550033/openai-teams-up-with-iphone-designer-jony-ive-as-chatgpt-maker-makes-push-into-hardware-apple-shares-slide">held a 23% stake in io Products</a> before moving to full acquisition. The transaction requires regulatory approval and is expected to close within months, positioning OpenAI to compete directly with established hardware manufacturers in the emerging AI device market.
Apple&#8217;s stock has a negative price trend over the short to long term, but it performs well on quality metrics, <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">according to Benzinga Edge Stock Rankings</a>. Growth and momentum performance for AAPL are modest, and the company&#8217;s valuation seems low. 
<figure class="wp-block-image aligncenter size-full is-resized"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/22060151/Screenshot-2025-05-22-at-3.25.02%E2%80%AFPM.png" alt="" class="wp-image-924108" style="width:628px;height:auto" /></a></figure>
Image Via Shutterstock 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/bonds/25/05/45557372/jim-cramer-says-bonds-will-overshoot-and-then-settle-predicts-turbocharged-economy-from-budget-agreement">Jim Cramer Says Bonds Will &#8216;Overshoot And Then Settle,&#8217; Predicts Turbocharged Economy From Budget Agreement</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

Tech

AAPL

GOOG

GOOGL

Apple Faces 'First Serious Threat In 20 Years' As OpenAI Acquires iPhone Maker's Former Design Chief Jony Ive's Hardware Startup, Says Gene Munster

Institutional investors are quietly ramping up bearish bets, signaling a level of caution that market watchers say hasn't been seen in years.
What Happened: On Wednesday, popular investment newsletter The Kobeissi Letter posted on X, showing the substantial rise in the short interest of a median S&amp;P 500 stock, which is now at 2.3%, the highest in 7 years.
The post notes that the short interest as a percentage of shares outstanding has risen 35% year-to-date, which it says is comparable with the move seen at the beginning of the 2008 financial crisis. 
See Also: <a href="https://www.benzinga.com/markets/equities/25/05/45559242/short-seller-andrew-lefts-citron-doubles-down-on-duolingo-short-says-googles-ai-tool-changes-the-business">Short Seller Andrew Left&#8217;s Citron Doubles Down On Duolingo Short, Says Google&#8217;s AI Tool Changes The Business</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: Short interest on the median S&amp;P 500 stock has surged to ~2.3%, the highest in 7 years. Short interest as a % of shares outstanding has risen 35% year-to-date. This is a comparable move to the one seen at the beginning of the 2008 Financial Crisis, but starting from a… <a href="https://t.co/eLpi3vTkOq">pic.twitter.com/eLpi3vTkOq</a>
&mdash; The Kobeissi Letter (@KobeissiLetter) <a href="https://twitter.com/KobeissiLetter/status/1925302833928122689?ref_src=twsrc%5Etfw">May 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While the recent surge begins from a much lower base, the strength of the trend mirrors the defensive positioning seen just before the last major market collapse.
This also marks the first time short interest has breached its long-term historical average since the retail-fueled short squeeze frenzy in 2021, according to Goldman Sachs.
According to the post, hedge fund short interest on Nasdaq-listed stocks now accounts for 41% of total open interest, which is once again the highest level since February 2021. 
The post concludes by saying that &#8220;institutional investors are betting on a stock market decline.&#8221;
Why It Matters: On Wednesday, investor Jeremy Grantham warned that the stock market could plunge <a href="https://benzinga.com/markets/equities/25/05/45532892/legendary-investor-jeremy-grantham-warns-of-50-stock-market-crash">as much as 50%</a>, pointing to distortions fueled by pandemic-era liquidity and the AI-boom in a handful of &#8220;Mag 7&#8221; stocks as having skewed market dynamics.
&#8220;The market could easily go down by 50% and be well within its historical boundary. That would not be a colossal low,&#8221; Grantham said.
JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon warned early this week that <a href="https://www.benzinga.com/markets/equities/25/05/45535142/jamie-dimon-who-flagged-trouble-before-2008-lehman-brothers-collapse-now-warns-sp-earnings-could-fall-to-0rougher-time-for-markets-says-dan-niles">S&amp;P 500 earnings growth</a> could drop from 12% to 0%.
He also said that current asset prices were &#8220;kind of high,&#8221; while credit spreads remain &#8220;kind of low.&#8221;
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45559059/trumps-big-beautiful-bill-could-be-3-1-trillion-jackpot-for-affluent-americans-like-elon-musk-and-jeff-bezos-report">Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Could Be $3.1 Trillion Jackpot For Affluent Americans Like Elon Musk And Jeff Bezos: Report</a></li>
</ul>
Image Via Shutterstock

Short Interest Surges Across S&P 500: Institutional Investors Bet Against Market At Scale Not Seen Since 2008

PSNL

Personalis To Unveil Data Supporting ctDNA As Prognostic Tool In TNBC And Immunotherapy Response At Upcoming ASCO Sessions

Instil Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIL#NASDAQ">TIL</a>, ", Instil", ))) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, "ImmuneOnco"), today announced clinical trial updates of ‘2510 and NSCLC clinical development strategy.
"We are delighted with the significant clinical advancements by our collaborator, ImmuneOnco, with ‘2510 for NSCLC in China," said Bronson Crouch, CEO of Instil. "We are confident that ‘2510 has the potential to emerge as a leading PD-(L)1xVEGF bispecific antibody, and we look forward to the initial results from the ongoing first-line chemotherapy combination trial in China. In parallel, we are advancing preparations to initiate U.S. clinical development later this year, and we look forward to bringing this potential important new medicine to patients globally."
Dr. Tian Wenzhi, CEO of ImmuneOnco, said, "Our collaboration on ‘2510 has achieved meaningful progress. We are actively conducting a Phase 2 clinical trial of ‘2510 in combination with chemotherapy in patients with first-line NSCLC. The data generated to date underscore its best-in-class potential within the promising PD-(L)1xVEGF class. We anticipate sharing further clinical data in the second half of 2025."
Phase 2 Trial of&nbsp;‘2510 in Combination with Chemotherapy in First-line NSCLC
<ul>
<li>ImmuneOnco expects to complete enrollment of approximately 60 patients in Q3 2025 in its Phase 2 trial of ‘2510 in combination with chemotherapy in patients with NSCLC in the first-line setting in China.</li>
<li>Among more than 30 NSCLC patients enrolled (including the safety run-in), more than 20 first-line NSCLC patients have been treated since the end of March.</li>
<li>ImmuneOnco anticipates sharing initial safety and efficacy results from this Phase 2 trial in the second half of 2025.</li>
</ul>
‘2510 Monotherapy Data in Relapsed/Refractory&nbsp;NSCLC (China)
<ul>
<li>The objective response rate (ORR) is similar to datasets from competitor PD-(L)1xVEGF bispecific antibodies at a similar stage of development in patients with previously treated NSCLC, showing ORR of 23% (efficacy evaluable n=13).</li>
<li>The updated clinical safety from the full ‘2510 monotherapy trial (n=106) and efficacy data in NSCLC are further detailed in a new corporate deck posted on Instil Bio's investor relations webpage at <a href="https://ir.instilbio.com/news-events/presentations">https://ir.instilbio.com/news-events/presentations</a>.</li>
</ul>
Other ‘2510 Clinical and Preclinical Updates
<ul>
<li>Instil's Phase 1b/2 trial of ‘2510 in the United States is expected to be initiated before the end of 2025, assuming the necessary regulatory approvals are obtained. The trial is expected to be a monotherapy dose optimization trial in relapsed/refractory solid tumors, which is intended to bridge the doses to the ongoing China trials and replaces the previously planned US ‘2510 and chemotherapy combination trial in first-line NSCLC.
<ul>
<li>Instil believes that this change may accelerate the path to initiating a potential global Phase 3 trial in first-line NSCLC.</li>
</ul>
</li>
<li>Preclinical assays demonstrate cooperative binding of ‘2510 to PD-L1 in the presence of VEGF in vitro. Further preclinical datasets demonstrating the unique and potentially best-in-class mechanism of action of ‘2510 are anticipated to be presented at future medical or scientific conferences.</li>
</ul>

Instil Bio, ImmuneOnco Advance Lung Cancer Drug '2510 With New Trials in China and US Plans Ahead

Toronto-Dominion Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>) reported quarterly earnings of $1.37 per share which missed the analyst consensus estimate of $1.75 by 21.71 percent. This is a 8.67 percent decrease over earnings of $1.50 per share from the same period last year. The company reported quarterly sales of $15.98 billion which beat the analyst consensus estimate of $13.84 billion by 15.46 percent. This is a 56.85 percent increase over sales of $10.19 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Toronto-Dominion Bank Q2 Adj. EPS $1.37 Misses $1.75 Estimate, Sales $15.98B Beat $13.84B Estimate

Atour Lifestyle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.32 by 6.25 percent. This is a 30.77 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $262.63 million which beat the analyst consensus estimate of $259.06 million by 1.38 percent. This is a 29.15 percent increase over sales of $203.36 million the same period last year.

Atour Lifestyle Holdings Q1 Adj. EPS $0.34 Beats $0.32 Estimate, Sales $262.63M Beat $259.06M Estimate

Venture capitalist Marc Andreessen in 2023 said that artificial intelligence could function as an economic catalyst. However, Mark Cuban believes entrenched corporate interests will resist letting it flourish freely.
What Happened: In a sweeping essay and subsequent interviews, the a16z co-founder described AI as a productivity amplifier—one that could increase wages, reduce costs, and spark broad economic growth.
He predicted that capitalist incentives would eventually drive companies to scale AI access the way they did with smartphones and electric cars.
However, when the video resurfaced online on Wednesday, billionaire entrepreneur Cuban offered a stark rebuttal.
See Also:&nbsp;<a href="https://www.benzinga.com/media/25/03/44508019/tesla-and-other-us-robotics-giants-demand-federal-strategy-to-compete-with-chinas-138-billion-push-warn-america-will-lose-the-race-without-it" target="_blank" rel="noreferrer noopener">Tesla And Other US Robotics Giants Demand Federal Strategy To Compete With China's $138 Billion Push — Warn America Will Lose The Race Without It</a> "The issue is companies will do all they can to protect their IP and anything that impacts their competitiveness," Cuban wrote in a post on X, formerly Twitter, responding to Andreessen's optimism, adding they will do all they can to disrupt synthetic data creation.
While acknowledging the feasibility of Andreessen's vision, where optimization drives costs toward zero, Cuban compared it to the disruptive effect of fracking in the energy sector.
Still, he warned of intense corporate resistance. "Companies will spend unlimited amounts to create opacity and take adversarial actions to protect their margins. It will be nonstop fighting under the cloak of darkness."
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The issue is companies will do all they can to protect their IP and anything that impacts their competitiveness away from however AI consumes and accumulates training data. And will do all it can to disrupt synthetic data creation I think <a href="https://twitter.com/pmarca?ref_src=twsrc%5Etfw">@pmarca</a> is suggesting continuous… <a href="https://t.co/OSJUQYN9V3">https://t.co/OSJUQYN9V3</a>
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1925332797587169489?ref_src=twsrc%5Etfw">May 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It's Important: The debate underscores a broader tension over who will benefit from AI's rapid advancement. As governments grapple with how to regulate AI, the outcome could determine whether the technology becomes a public good or a walled-off asset benefiting only a few.
Earlier this month, Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang, in an interview, said that if he were a student today, he would leverage generative <a href="https://www.benzinga.com/tech/25/05/45485072/if-i-were-a-student-today-heres-how-id-use-ai-to-do-my-job-better-says-nvidia-ceo">AI to boost his career prospects</a>.
Although only 11% of young Americans use AI regularly, Huang remains confident that AI skills will remain relevant and valuable in the future.
Last month, during a discussion at Hamilton College in Upstate New York, former President Barack Obama cautioned that AI is now capable of outperforming "60–70% of programmers," implying that only "the best coders" may withstand the <a href="https://www.benzinga.com/news/25/05/45338146/obama-says-only-the-best-coders-will-survive-as-ai-takes-over-60-70-of-programming-jobs-you-just-wont-need-a-coder">impending wave of automation</a>.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/01/43373775/tim-cook-praises-chinas-deepseek-for-driving-efficiency-stresses-apples-prudent-and-deliberate-approach-toward-capital-expenditure" target="_blank" rel="noreferrer noopener">Tim Cook Praises China&#8217;s DeepSeek For Driving Efficiency, Stresses Apple&#8217;s ‘Prudent And Deliberate&#8217; Approach Toward Capital Expenditure</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

NVDA

Marc Andreessen Once Predicted That AI Could Save The Economy, But Mark Cuban Thinks Corporations Will Fight To Keep Profits High

Atour Lifestyle Holdings Limited ("Atour" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>), a leading hospitality and lifestyle company in China, today announced that as part of its commitment to enhancing shareholder value, the Board of Directors (the "Board") has (i) declared a dividend under its three-year annual dividend policy (the "Annual Dividend Policy") adopted in August 2024, and (ii) authorized a three-year share repurchase program of up to US$400 million (the "Share Repurchase Program").
Dividend
In accordance with the Annual Dividend Policy, as the first dividend payment in 2025, the Board today declared a cash dividend of US$0.14 per ordinary share, or US$0.42 per American depositary share ("ADS"). Each ADS represents three Class A ordinary shares. The aggregate amount of the cash dividend to be distributed will be approximately US$58 million.
The cash dividend will be payable in U.S. dollars on or around June 18, 2025 to the holders of record of the Company's ordinary shares (excluding certain Class A ordinary shares previously held by The Bank of New York Mellon, as the depositary bank, for bulk issuance of ADSs reserved under the Company's share incentive plan) and ADSs as of the close of trading on June 2, 2025 (U.S. Eastern Time). Dividends to be paid to the Company's ADS holders through the depositary will be subject to the terms of the deposit agreement by and among the Company, the depositary, and the holders and beneficial owners of ADS issued thereunder, including the fees and expenses payable thereunder.
The Board adopted the Annual Dividend Policy in August 2024, under which the Company plans to declare and distribute dividends with an aggregate amount of no less than 50% of its net income for the preceding financial year in each of the three financial years commencing in 2024. Under the Annual Dividend Policy, the exact dividend amount will be determined at the Board's discretion based on its assessment of the Company's actual and projected results of operations, financial and cash position, capital requirements and other relevant factors.
Share Repurchase Program
On the same day, the Board authorized the three-year Share Repurchase Program under which the Company may repurchase up to US$400 million in value of its ordinary shares and/or ADSs.
The Company's proposed repurchases may be made from time to time on the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the SEC Rule 10b-18 and/or Rule 10b5-1 requirements. The Board will review the share repurchase program periodically, and may authorize adjustment of its terms and size. The Company expects to fund the repurchases out of its existing cash balance.
As of March 31, 2025, the Company had approximately RMB3.1 billion (US$434 million) in cash, cash equivalents and restricted cash.

Dividends

Buybacks

Atour Unveils $400M Buyback Plan to Boost Shareholder Value Over Next Three Years, Declares $0.42 Per ADS Dividend

Dorian LPG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPG#NYSE">LPG</a>) reported quarterly earnings of $0.25 per share which missed the analyst consensus estimate of $0.75 by 66.67 percent. This is a 86.91 percent decrease over earnings of $1.91 per share from the same period last year. The company reported quarterly sales of $75.89 million which missed the analyst consensus estimate of $97.00 million by 21.77 percent. This is a 46.33 percent decrease over sales of $141.39 million the same period last year.

Dorian LPG Q4 Adj. EPS $0.25 Misses $0.75 Estimate, Sales $75.89M Miss $97.00M Estimate

U.S. stock futures swung on Thursday after two days of decline on Wednesday. Futures of major benchmark indices were trading mixed in premarket.
After a marathon 22-hour hearing, the <a href="https://www.benzinga.com/25/05/45558613/house-advances-trumps-sweeping-one-big-beautiful-bill-after-key-medicaid-tax-and-border-security-changes">House Rules Committee moved</a> President Donald Trump&#8216;s &#8220;$4.9 trillion legislative package&#8221; forward with an 8-4 vote on the &#8220;One Big Beautiful Bill Act.&#8221; 
This action paves the way for a potential overnight floor vote, as Republicans press ahead despite internal party disagreements.
Meanwhile, the 10-year Treasury bond yielded 4.57% and the two-year bond was at 3.99%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 94.7% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.06%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.13%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.04%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Thursday. The SPY was up 0.14% to $583.68, while the QQQ advanced 0.25% to $514.34, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Most S&amp;P 500 sectors closed lower Wednesday, with real estate, healthcare, and financial stocks seeing the largest declines.
However, communication services bucked the trend, finishing higher. Investors remained cautious amid fresh worries about fiscal policy.
Meanwhile, Lowe's Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) reported mixed first-quarter fiscal 2025 results, and Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) posted weaker-than-expected first-quarter figures.
On the economic front, U.S. mortgage application volumes fell 5.1% from the prior week for the period ending May 16.
The Dow Jones index declined 817 points or 1.91% to 41,860.44, whereas the S&amp;P 500 index fell 1.61% to 5,844.61. Nasdaq Composite ended 1.41% lower at 18,872.64, and the small-cap gauge, Russell 2000, dropped 2.80% to 2,046.56.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-1.41%</td>
<td>18,872.64</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.61%</td>
<td>5,844.61</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.91%</td>
<td>41,860.44</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.80%</td>
<td>2,046.56</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
The Senior Global Market Strategist at Wells Fargo, Scott Wren, said that &#8220;We do not see the U.S. economy dipping into a recession this year as consumer spending should continue to grow modestly with growth in real incomes.&#8221;
Wren anticipates a modest rebound in GDP next year, rising to 1.8% from their projected 1% for this year, following a continued growth slowdown over the next couple of quarters.
Wells Fargo doesn&#8217;t foresee a U.S. recession this year because consumer spending should continue its modest growth, bolstered by increasing real incomes, even if it&#8217;s weaker than late last year.
While unemployment is expected to tick up due to below-average economic growth, Wells Fargo&#8217;s 5.3% projection for 2026 remains well below recessionary levels.
Furthermore, he added that &#8220;We also still see plenty of up and down in equity prices but ultimately a higher S&amp;P 500 Index by the end of 2026.&#8221;
Meanwhile, Kristian Kerr, head of macro strategy at LPL Financial, said that &#8220;Greater clarity is expected later this summer, as economic data tends to lag, meaning the full impact of tariffs may not be evident until June or July at the earliest.&#8221;
Additionally, he explained that the current policy landscape remains in flux, with broader tariffs largely paused until early July and China exempt from significant tariff increases until August 12.
&#8220;If meaningful economic weakness does materialize — confirmed by hard data mirroring the softness seen in leading indicators — or trade negotiations deteriorate, another bout of market volatility could ensue, potentially aligning with historical seasonal patterns where equities often struggle from late summer into fall.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday:
<ul class="wp-block-list">
<li>Initial jobless claims data for the week ending May 17 will be out by 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>The S&amp;P flash U.S. services and manufacturing PMI for May will be released by 9:45 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>April&#8217;s existing home sales will be announced by 10:00 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>New York Fed President John Williams will speak at 2:00 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>BJ&#8217;s Wholesale Club Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) was up 0.51% in premarket on Thursday as analysts expect it to report quarterly earnings of 91 cents per share on revenue of $5.20 billion, before the opening bell.</li>
<li>Analog Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) advanced 1.16% as Wall Street expects it to report earnings before the opening bell. It is expected to post earnings of $1.70 per share on revenue of $2.51 billion.</li>
<li>Williams-Sonoma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) was 0.048% higher as analysts expect it to report quarterly earnings of $1.76 per share on revenue of $1.67 billion, before the opening bell.</li>
<li>Advance Auto Parts Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) rose 1.25% as Wall Street expects it to report earnings before the opening bell. It is expected to post a quarterly loss of 69 per share on revenue of $2.51 billion.</li>
<li>Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) jumped 9.54% after posting better-than-expected earnings and sales results for the first quarter. The company also said it expects second-quarter product revenue in the range of $1.035 billion to $1.04 billion, up approximately 25% year-over-year.</li>
<li>Zoom Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) was 0.17% higher after reporting stronger-than-expected earnings for its first quarter after Wednesday's closing bell.</li>
<li>Urban Outfitters Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) surged 17.50% after posting a better-than-expected first quarter result and highlighting diversification strategies to mitigate tariffs in its earnings call.</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) was up 0.13% after announcing the acquisition of Johnson Matthey&#8216;s Catalyst Technologies business, expanding its portfolio of leading catalyst and process technologies.</li>
<li>Rio Tinto PLC ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) advanced 0.58% after announcing the start of early works and final studies to increase Amrun mine's bauxite production on Queensland's Cape York Peninsula.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.20% to hover around $60.83 per barrel.
Gold Spot US Dollar fell 0.10% to hover around $3,312.13 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was higher by 0.169% at the 99.7170 level.
Asian markets were lower on Thursday as South Korea's Kospi, India's S&amp;P BSE Sensex, Japan's Nikkei 225, Australia's ASX 200, Hong Kong's Hang Seng, and China&#8217;s CSI 300 indices declined. European markets were also lower in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45541408/cathie-woods-ark-invest-says-nuclear-energy-could-overtake-solar-as-cheapest-power-source-heres-a-list-of-nuclear-energy-linked-etfs-to-consider">Cathie Wood&#8217;s Ark Invest Says Nuclear Energy Could Overtake Solar As Cheapest Power Source: Here&#8217;s A List Of Nuclear Energy Linked ETFs To Consider </a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Futures

Pre-Market Outlook

SNOW

URBN

US Stock Likely To Open On A Mixed Note After 2-Day Fall: 'We Do Not See The US Economy Dipping Into A Recession This Year,' Says Expert

Needham analyst Mike Matson reiterates Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) from Hold to Hold.

Reiteration

Analyst Ratings

Needham Reiterates Hold on Medtronicto Hold

Shares of Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) rose sharply in today's pre-market following better-than-expected <a href="https://in.benzinga.com/markets/equities/25/05/45559366/urban-outfitters-navigates-tariff-headwinds-with-diversification-strategies-no-country-accounts-for-more-than-25-of-production">first-quarter financial results.</a>
Urban Outfitters reported quarterly earnings of $1.16 per share, which beat the analyst consensus estimate of 82 cents. Quarterly revenue clocked in at $1.33 billion, which beat the Street estimate of $1.28 billion.
Urban Outfitters shares jumped 18% to $70.32 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) rose 172.2% to $5.20 in pre-market trading after NVIDIA selected the company to collaborate on 800 V HVDC architecture.</li>
<li>Longevity Health Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) surged 60.1% to $4.87 in pre-market trading after the company announced it will retain its Nasdaq listing to complete its merger with 20/20 Biolabs.</li>
<li>AtlasClear Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NYSE">ATCH</a>) jumped 23.2% to $0.2487 in pre-market trading after falling 11% on Wednesday.</li>
<li>Bit Origin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) gained 20.9% to $0.1920 in pre-market trading after declining 9% on Wednesday.</li>
<li>Nine Energy Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NINE#NYSE">NINE</a>) surged 19.7% to $0.6057 in pre-market trading after falling 10% on Wednesday.</li>
<li>Kindly MD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) gained 16.9% to $26.69 in pre-market trading. Nakamoto Holdings, Kindly MD, and Anchorage Digital disclosed a strategic partnership to advance the future of corporate Bitcoin adoption.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) climbed 14.6% to $4.37 in pre-market trading after the company announced the sale of its consumer fiber-to-the-home business to AT&amp;T for $5.75 billion in cash.</li>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) gained 11.4% to $10.14 in pre-market trading after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) rose 10.3% to $197.52 in pre-market trading after the company posted better-than-expected earnings and sales results for the first quarter. The company also said it expects second-quarter product revenue in the range of $1.035 billion to $1.04 billion, up approximately 25% year-over-year. The company anticipates full-year product revenue of $4.33 billion, representing 25% year-over-year growth.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>CEL-SCI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVM#NYSE">CVM</a>) shares fell 43.7% to $2.54 in pre-market trading after the company reported the pricing of public offering.</li>
<li>Catheter Precision, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#NYSE">VTAK</a>) fell 18.8% to $0.2450 in pre-market trading. Catheter Precision filed for resale of up to 12.9 million shares of common stock by the selling stockholders.</li>
<li>Wheeler Real Estate Investment Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>) fell 16.1% to $0.89 in today's pre-market trading after announcing a 1-for-7 reverse stock split.</li>
<li>Lottery.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) shares dipped 15.2% to $1.51 in pre-market trading. Lottery.com shares jumped 135% on Wednesday after the company reported a year-over-year increase in first-quarter EPS results.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares tumbled 15.1% to $9.05 in pre-market trading after declining around 8% on Wednesday.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) fell 13.7% to $0.0259 in pre-market trading. Digital Ally shares fell around 17% on Wednesday after the company reported a year-over-year decrease in first-quarter sales results.</li>
<li>Vast Renewables Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) dipped 13.6% to $0.1450 in pre-market trading after tumbling 10% on Wednesday.</li>
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) declined 9.5% to $11.56 in pre-market trading after gaining over 29% on Wednesday.</li>
<li>Manchester United plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) shares fell 6.9% to $13.54 in pre-market trading.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) fell 5.2% to $18.81 in pre-market trading. GLJ Research analyst Gordon Johnson, on Wednesday, maintained SolarEdge with a Sell and raised the price target from $3.9 to $6.9.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/25/05/45540545/jim-cramer-recommends-not-buying-mosaic-doesnt-like-this-industrial-stock">Jim Cramer Recommends Not Buying Mosaic, Doesn&#8217;t Like This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

ATCH

BTOG

DGLY

KDLY

LTRY

LUMN

MANU

NINE

NVTS

SEDG

UPXI

VSTE

VTAK

WHLR

Longevity Health Holdings, Inc. - Common Stock

XAGE

Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) CEO Marc Benioff credits a pivotal 2010 conversation with Apple Inc. co-founder Steve Jobs for shaping the focused product strategy that helped build his company&#8217;s $270.8 billion market capitalization.
What Happened: Speaking at the 2024 All-In Summit with President Donald Trump&#8216;s White House AI &amp; Crypto Czar David Sacks, Benioff recalled how Jobs summoned him to discuss Apple&#8217;s product philosophy during the iPad&#8217;s development phase.
&#8220;After I started Salesforce, he gave me really key advice,&#8221; Benioff said. &#8220;It was 2010 and he calls me, &#8216;Come down here, I need to talk to you.'&#8221;
During the meeting, Jobs demonstrated two iPad prototypes before explaining his &#8220;one A Team&#8221; philosophy. &#8220;We only have one A Team here. One A Team. So we&#8217;re only focused on one thing at a time,&#8221; Jobs told Benioff, according to the Salesforce CEO&#8217;s account.
Jobs then placed five or six products on his coffee table, telling Benioff: &#8220;We will never have more products than can fit on my coffee table. One focus at a time. Remember that, Marc. That&#8217;s the way you need to run Salesforce.&#8221;
See Also: <a href="https://www.benzinga.com/markets/equities/25/05/45535142/jamie-dimon-who-flagged-trouble-before-2008-lehman-brothers-collapse-now-warns-sp-earnings-could-fall-to-0rougher-time-for-markets-says-dan-niles">Jamie Dimon, Who Flagged Trouble Before 2008 Lehman Brothers Collapse, Now Warns S&amp;P Earnings Could Fall To 0%: &#8216;Rougher Time For Markets,&#8217; Says Dan Niles</a>
Why It Matters: This focused approach has proven successful for Salesforce, which generated an estimated $7.9 billion in Sales Cloud subscription revenue for fiscal 2026. BofA Securities analyst Brad Sills maintains a Buy rating with a $350 price target, citing the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45357365/salesforce-sales-cloud-ai-integration-and-cloud-upsells-drive-analyst-confidence-in-long-term-growth">company&#8217;s core growth businesses and AI integration</a> through its Agentforce platform.
Benioff, who worked as an assembly language programmer at Apple in 1984, has applied Jobs&#8217; philosophy while expanding Salesforce beyond its original CRM software into what he calls &#8220;digital labor&#8221; markets. The company&#8217;s Sales Cloud maintains an <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45357365/salesforce-sales-cloud-ai-integration-and-cloud-upsells-drive-analyst-confidence-in-long-term-growth">estimated 25% share of the $39 billion Sales CRM industry</a>, according to Gartner forecasts.
Salesforce Ventures, with $6.8 billion under management, recently scored approximately $600 million when Google acquired cybersecurity firm Wiz. The company&#8217;s $1 billion Generative AI Fund has invested in Anthropic and other AI startups, <a href="https://www.benzinga.com/startups/25/05/45436500/salesforce-ceo-marc-benioff-says-funding-thousands-of-startups-is-how-innovation-happens-youre-going-to-throw-a-lot-against-the-wall">reflecting Benioff&#8217;s belief</a> that &#8220;you must fund the chaos to harvest the miracles.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Marc Benioff &#x7C; All-In Summit 2024" width="500" height="281" src="https://www.youtube.com/embed/TtNrCJCwwlc?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Image Via Shutterstock 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45558772/google-and-character-ai-sued-after-teen-dies-following-interaction-with-game-of-thrones-themed-chatbot-judge-says-free-speech-defense-not-acceptable">Google And Character.AI Sued After Teen Dies Following Interaction With &#8216;Game Of Thrones&#8217;-Themed Chatbot — Judge Says Free Speech Defense Not Acceptable</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Success Stories

Steve Jobs Once Invited Marc Benioff To His Office With 2 iPads In 2010: The Lesson That Shaped A $270 Billion Salesforce Empire

The Trump administration has made an urgent plea to the Supreme Court to prevent Elon Musk&#8216;s Department of Government Efficiency (DOGE) from disclosing its operational documents&nbsp;to a federal watchdog group.
What Happened: The administration made the appeal on Wednesday, asking the Supreme Court to overturn court orders requiring DOGE to share its operational documents with Citizens for Responsibility and Ethics in Washington (CREW), <a href="https://apnews.com/article/supreme-court-doge-freedom-information-records-trump-14a1773b42ddad1e3367a39750a84bef">reported</a> AP News.
The Justice Department maintains that DOGE, a significant component of President Trump&#8217;s government reform initiatives, is a presidential advisory body and therefore not subject to Freedom of Information Act (FOIA) requests.
In February, CREW initiated a lawsuit claiming that DOGE&nbsp;wields considerable power without any transparency about its activities.&nbsp;In March, U.S. District Judge&nbsp;Christopher Cooper&nbsp;ruled that DOGE&#8217;s role likely goes beyond advisory, noting its role in the closure of USAID and the reduction of billions in government contracts.&nbsp;
Cooper has given the administration a compliance deadline of June 13. Solicitor General D. John Sauer urged the justices to act swiftly, calling Cooper's orders "extraordinarily overbroad and intrusive."
SEE MORE:&nbsp;<a href="https://benzinga.com/markets/25/05/45539686/kevin-oleary-warns-trumps-big-beautiful-bill-could-be-devastating-for-small-businesses-somebodys-got-to-r" target="_blank" rel="noreferrer noopener">Kevin O&#8217;Leary Warns Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Could Be &#8216;Devastating&#8217; For Small Businesses: &#8216;Somebody&#8217;s Got To Raise The Red Flag&#8217;</a>
Why It Matters:&nbsp;This latest development is part of a series of legal battles surrounding DOGE&#8217;s authority and operations. Earlier this month, the Trump administration&nbsp;sought Supreme Court <a href="https://www.benzinga.com/news/25/05/45189902/trump-administration-pushes-supreme-court-to-greenlight-doge-access-to-americans-social-security-data-despite-lower-courts-fishing-expedition-warning">approval&nbsp;</a>for DOGE to access sensitive Social Security data, despite a lower court&#8217;s ruling against this. This move further escalated the ongoing dispute over data privacy and executive authority.
Elon Musk, the CEO of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), has been at the center of these controversies. Musk&#8217;s DOGE has been&nbsp;<a href="https://www.benzinga.com/25/04/44778750/musks-government-efficiency-push-falls-short-as-treasury-data-shows-spending-up-sharply-under-trumps-second-term-report">aggressively cutting costs</a>, yet federal spending has reportedly increased by $154 billion since Trump&#8217;s second term began. This has raised questions about the effectiveness and impact of DOGE&#8217;s actions.
When CNBC&#8217;s David Faber asked Musk on Tuesday about the <a href="https://www.benzinga.com/media/25/05/45534314/elon-musk-just-got-grilled-on-doge-spending-hits-back-with-were-not-kings-here">concrete results</a> of DOGE&#8217;s cost-cutting measures, pointing out the criticism Musk has received, Musk replied: "We are advisers. We are not—we&#8217;re not kings here." Previously, Musk had accepted that DOGE hadn&#8217;t been <a href="https://www.benzinga.com/markets/25/05/45163408/doge-not-as-effective-as-id-like-says-elon-musk-calls-reform-really-difficult-like-changing-direction-of-a-fleet-of-supertankers">as effective</a> as he&#8217;d like. 
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/25/05/45541866/xi-jinpings-china-wants-trump-to-immediately-drop-the-golden-dome-project-over-strong-offensive-implicati" target="_blank" rel="noreferrer noopener">Xi Jinping&#8217;s China Wants Trump To Immediately Drop The Golden Dome Project Over &#8216;Strong Offensive Implications:&#8217; &#8216;&#8230;Security Of All Countries Should Not Be Compromised&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

TSLA

Trump Admin Urges Supreme Court To Block Watchdog From Accessing Elon Musk's DOGE Records

Macro Economic Events

Econ #s

Economics

U.K. Services Purchasing Managers Index Preliminary For May 50.2 Vs. 50.0 Est.; 49.0 Prior

U.K. Manufacturing Purchasing Managers Index Preliminary For May 45.1 Vs. 46.2 Est.; 45.4 Prior

U.K. Composite Purchasing Managers' Index Preliminary For May 49.4 Vs. 49.3 Est.; 48.5 Prior

Press Releases

CFSB BANCORP, INC. ANNOUNCES FISCAL FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

CFSB BANCORP, INC. ANNOUNCES FISCAL FIRST QUARTER 2025 FINANCIAL RESULTS

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2025 FINANCIAL RESULTS

CFSB BANCORP, INC. ANNOUNCES FISCAL THIRD QUARTER AND YEAR-TO-DATE 2025 FINANCIAL RESULTS

Comments

CFSB Bancorp

CFSB Bancorp (CFSB) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL